BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21573016)

  • 21. FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51.
    Zhang N; Wu X; Yang L; Xiao F; Zhang H; Zhou A; Huang Z; Huang S
    Clin Cancer Res; 2012 Nov; 18(21):5961-71. PubMed ID: 22977194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rad51 and BRCA2--New molecular targets for sensitizing glioma cells to alkylating anticancer drugs.
    Quiros S; Roos WP; Kaina B
    PLoS One; 2011; 6(11):e27183. PubMed ID: 22073281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins.
    Kitange GJ; Mladek AC; Schroeder MA; Pokorny JC; Carlson BL; Zhang Y; Nair AA; Lee JH; Yan H; Decker PA; Zhang Z; Sarkaria JN
    Cell Rep; 2016 Mar; 14(11):2587-98. PubMed ID: 26972001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein.
    Fei P; Yin J; Wang W
    Cell Cycle; 2005 Jan; 4(1):80-6. PubMed ID: 15611632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.
    Kanai R; Rabkin SD; Yip S; Sgubin D; Zaupa CM; Hirose Y; Louis DN; Wakimoto H; Martuza RL
    J Natl Cancer Inst; 2012 Jan; 104(1):42-55. PubMed ID: 22173583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair.
    Goellner EM; Grimme B; Brown AR; Lin YC; Wang XH; Sugrue KF; Mitchell L; Trivedi RN; Tang JB; Sobol RW
    Cancer Res; 2011 Mar; 71(6):2308-17. PubMed ID: 21406402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.
    Wilson JB; Blom E; Cunningham R; Xiao Y; Kupfer GM; Jones NJ
    Mutat Res; 2010 Jul; 689(1-2):12-20. PubMed ID: 20450923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients.
    Agnihotri S; Gajadhar AS; Ternamian C; Gorlia T; Diefes KL; Mischel PS; Kelly J; McGown G; Thorncroft M; Carlson BL; Sarkaria JN; Margison GP; Aldape K; Hawkins C; Hegi M; Guha A
    J Clin Invest; 2012 Jan; 122(1):253-66. PubMed ID: 22156195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
    Tacconi EM; Lai X; Folio C; Porru M; Zonderland G; Badie S; Michl J; Sechi I; Rogier M; Matía García V; Batra AS; Rueda OM; Bouwman P; Jonkers J; Ryan A; Reina-San-Martin B; Hui J; Tang N; Bruna A; Biroccio A; Tarsounas M
    EMBO Mol Med; 2017 Oct; 9(10):1398-1414. PubMed ID: 28729482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton beam therapy with concurrent chemotherapy for glioblastoma multiforme: comparison of nimustine hydrochloride and temozolomide.
    Mizumoto M; Yamamoto T; Ishikawa E; Matsuda M; Takano S; Ishikawa H; Okumura T; Sakurai H; Matsumura A; Tsuboi K
    J Neurooncol; 2016 Oct; 130(1):165-170. PubMed ID: 27535747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fanconi anemia complementation group FANCD2 protein serine 331 phosphorylation is important for fanconi anemia pathway function and BRCA2 interaction.
    Zhi G; Wilson JB; Chen X; Krause DS; Xiao Y; Jones NJ; Kupfer GM
    Cancer Res; 2009 Nov; 69(22):8775-83. PubMed ID: 19861535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
    Lan F; Pan Q; Yu H; Yue X
    J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chloroethylating anticancer drug ACNU induces FRA1 that is involved in drug resistance of glioma cells.
    Meise R; Tomicic MT; Kaina B; Christmann M
    Biochim Biophys Acta; 2012 Jul; 1823(7):1199-207. PubMed ID: 22609303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways.
    Hussain S; Wilson JB; Medhurst AL; Hejna J; Witt E; Ananth S; Davies A; Masson JY; Moses R; West SC; de Winter JP; Ashworth A; Jones NJ; Mathew CG
    Hum Mol Genet; 2004 Jun; 13(12):1241-8. PubMed ID: 15115758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elucidation of the Fanconi Anemia Protein Network in Meiosis and Its Function in the Regulation of Histone Modifications.
    Alavattam KG; Kato Y; Sin HS; Maezawa S; Kowalski IJ; Zhang F; Pang Q; Andreassen PR; Namekawa SH
    Cell Rep; 2016 Oct; 17(4):1141-1157. PubMed ID: 27760317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness.
    Bandey I; Chiou SH; Huang AP; Tsai JC; Tu PH
    Oncogene; 2015 Apr; 34(14):1853-64. PubMed ID: 24793792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2.
    Schlacher K; Wu H; Jasin M
    Cancer Cell; 2012 Jul; 22(1):106-16. PubMed ID: 22789542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells.
    Yamamoto K; Ishiai M; Matsushita N; Arakawa H; Lamerdin JE; Buerstedde JM; Tanimoto M; Harada M; Thompson LH; Takata M
    Mol Cell Biol; 2003 Aug; 23(15):5421-30. PubMed ID: 12861027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temozolomide: mechanisms of action, repair and resistance.
    Zhang J; Stevens MF; Bradshaw TD
    Curr Mol Pharmacol; 2012 Jan; 5(1):102-14. PubMed ID: 22122467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.